Collin et al. [16,17] found that two folate pathway polymorphisms (MTR 2756A > G and SHMT1 1420C > T) and circulating concentrations of vitamin B12 were associated with an increased risk of prostate cancer. The gene discussed is SHMT1; the disease is Familial prostate cancer.